Your browser doesn't support javascript.
loading
Prognostic significance of p53 in the cancer of the larynx.
Assimakopoulos, D; Kolettas, E; Zagorianakou, N; Evangelou, A; Skevas, A; Agnantis, N J.
Afiliação
  • Assimakopoulos D; Department of Otorhinolaryngology, University of Ioannina Medical School, 451 10 Ioannina, Greece. dassimak@cc.uoi.gr
Anticancer Res ; 20(5B): 3555-64, 2000.
Article em En | MEDLINE | ID: mdl-11131662
p53 is a nuclear phosphoprotein acting as a transcription factor to regulate cell cycle progression and apoptosis, mediated by a number of target genes. p53 mutant proteins have lost a) the ability to act as sequence-specific transcription factors and b) their tumour suppressive properties. As p53 is the most commonly mutated gene in human cancer, including laryngeal squamous cell carcinoma, an aggressive and most frequent tumour of head and neck, it has attracted a great deal of interest as a prognostic factor, diagnostic tool and therapeutic target. This article reviews the current understanding of the prognostic significance of p53 in laryngeal squamous cell carcinoma. Immunohistochemical staining techniques and molecular genetics demonstrated that p53 activation is an early event in laryngeal squamous cell carcinogenesis but can not be used as a reliable prognostic marker.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Laríngeas / Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2000 Tipo de documento: Article País de afiliação: Grécia País de publicação: Grécia
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Laríngeas / Proteína Supressora de Tumor p53 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2000 Tipo de documento: Article País de afiliação: Grécia País de publicação: Grécia